Back to Horizon Portfolio
Coxinova-90
Coxinova-90

Scientific Formulation

Coxinova-90

The Most Novel Painkiller. Coxinova-90 is a high-precision selective COX-2 inhibitor designed for superior pain management with an uncompromising gastrointestinal safety profile.

Molecular Composition

Etoricoxib 90 mg Tablet

Therapeutic Matrix

  • 106x COX-2 Selectivity
  • Superior GI Safety
  • Once-Daily Compliance
  • Novel Pain Neutralization

Mechanisms of Action

Etoricoxib 90mg

Provides targeted inhibition of the COX-2 enzyme with 106 times more selectivity than conventional NSAIDs, protecting the gastric mucosa while stopping pain.

Clinical Advantage

Specifically engineered for long-term management of Osteoarthritis, Rheumatoid Arthritis, and Spondylosis without the typical GI risks of traditional therapy.

Precision Healthcare for Everyone

BrandBrand